- Trials with a EudraCT protocol (329)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
329 result(s) found for: Dor procedure.
Displaying page 1 of 17.
EudraCT Number: 2011-005612-28 | Sponsor Protocol Number: 2011-11-11 | Start Date*: 2012-02-27 | ||||||||||||||||
Sponsor Name:Hannu Kokki | ||||||||||||||||||
Full Title: Pharmacokinetics of oxycodone in preterm and in infants | ||||||||||||||||||
Medical condition: Severe pain states which need oxycodone analgesia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-000404-25 | Sponsor Protocol Number: 1358.1 | Start Date*: 2016-05-02 | ||||||||||||||||
Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | ||||||||||||||||||
Full Title: A randomized, controlled multi-centre parallel group study to assess the efficacy and safety of multiple doses of a topically applied combination containing diclofenac 2% + capsaicin 0.075% (2 g fo... | ||||||||||||||||||
Medical condition: Acute back pain or acute neck pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-002155-10 | Sponsor Protocol Number: AHM001 | Start Date*: 2016-05-29 | |||||||||||
Sponsor Name:FISEVI Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla | |||||||||||||
Full Title: Effect of topical bromfenac 0.9 mg / ml in the perception of pain after intravitreal injection of drugs | |||||||||||||
Medical condition: Following the intravitreal injection of various drugs, very common procedure in clinical practice in ophthalmology, pain often occurs to varying degrees, although in most cases it is a painless pro... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004235-39 | Sponsor Protocol Number: 20140929sketamine | Start Date*: 2016-08-06 | |||||||||||||||||||||
Sponsor Name:Folktandvården, Landstinget Dalarna | |||||||||||||||||||||||
Full Title: Pain control in surgical intervention. Biomarkers in acute and chronical post operative pain | |||||||||||||||||||||||
Medical condition: Post operative pain | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: SE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002016-27 | Sponsor Protocol Number: KF5503/68 | Start Date*: 2015-03-23 | ||||||||||||||||
Sponsor Name:Grünenthal GmbH | ||||||||||||||||||
Full Title: Open-label evaluation of the pharmacokinetic profile, safety, and efficacy of tapentadol oral solution for the treatment of post-surgical pain in children and adolescents aged from 2 years to less ... | ||||||||||||||||||
Medical condition: Postoperative Pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020380-20 | Sponsor Protocol Number: R331333-PAI2005/KF5503-59 | Start Date*: 2012-03-09 | |||||||||||
Sponsor Name:Janssen Research & Development, L.L.C. | |||||||||||||
Full Title: Open-Label Evaluation of the Pharmacokinetic Profile and Safety of Tapentadol Oral Solution for the Treatment of Postsurgical Pain in Children and Adolescents Aged From 6 to Less Than 18 Years | |||||||||||||
Medical condition: Pain | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002778-21 | Sponsor Protocol Number: ESTEVE-SACO4-201 | Start Date*: 2012-01-12 | |||||||||||
Sponsor Name:Laboratorios del Dr. Esteve, S.A | |||||||||||||
Full Title: A randomized, double-blind, controlled with active treatment (tramadol 100 mg) and placebo, parallel groups, Phase II clinical trial to establish the effective dose between 4 strengths of E-58425 f... | |||||||||||||
Medical condition: Adult patients with moderate to severe dental pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000137-14 | Sponsor Protocol Number: PDC-01-0206 | Start Date*: 2021-05-04 | |||||||||||
Sponsor Name:Cessatech A/S | |||||||||||||
Full Title: Pharmacokinetic study of intranasal CT001 in children 1-17 years of age undergoing elective surgical procedures | |||||||||||||
Medical condition: Management of acute pain in children 1-17 years with the objective of preventing pain and distress associated with painful medical procedures in children. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000992-28 | Sponsor Protocol Number: KCT04/2015-DORETAonko/SI | Start Date*: 2015-07-15 | |||||||||||
Sponsor Name:Krka, d.d., Novo mesto | |||||||||||||
Full Title: A comparison of the severity of acute pain and the frequency of chronic pain after post-operative analgesia of lower and higher intensity following surgical emptying of the axillary gland in breast... | |||||||||||||
Medical condition: Acute pain after surgical emptying of the axillary gland in breast cancer patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000627-20 | Sponsor Protocol Number: F8394-201 | Start Date*: 2023-02-07 | ||||||||||||||||
Sponsor Name:Fore Biotherapeutics | ||||||||||||||||||
Full Title: A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations | ||||||||||||||||||
Medical condition: Tumors harboring BRAF alterations | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) SE (Trial now transitioned) DE (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002259-24 | Sponsor Protocol Number: KF5503-73 | Start Date*: 2015-03-16 | |||||||||||
Sponsor Name:Grünenthal GmbH | |||||||||||||
Full Title: Open-label evaluation of the population pharmacokinetic profile, safety, tolerability, and efficacy of intravenous tapentadol solution for injection for the treatment of post-surgical pain in child... | |||||||||||||
Medical condition: Severe post-operative pain | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) PL (Completed) GB (Completed) ES (Completed) CZ (Completed) FR (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005544-33 | Sponsor Protocol Number: AUH-TFB-SR-ULMR | Start Date*: 2016-02-08 | ||||||||||||||||
Sponsor Name:Thomas Fichtner Bendtsen | ||||||||||||||||||
Full Title: Shamrock – Ultrasound/MR image fusion guided lumbar plexus blocks | ||||||||||||||||||
Medical condition: Hip surgery anaesthesia and perioperative analgesia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-005384-31 | Sponsor Protocol Number: RSIv80 | Start Date*: 2021-03-19 | ||||||||||||||||
Sponsor Name:Rigshospitalet | ||||||||||||||||||
Full Title: A single blinded multicenter randomized study comparing intubating conditions during rapid sequence induction with either suxamethonium 1.0 mg/kg or rocuronium 1.0 mg/kg in elderly patients (≥ 80 y... | ||||||||||||||||||
Medical condition: The aim of this study is to determine the proportion of excellent tracheal intubation conditions at 60 seconds after administration of either rocuronium 1.0 mg/kg or suxamethonium 1 mg/kg in patien... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003310-40 | Sponsor Protocol Number: 1SPR11002 | Start Date*: 2014-01-27 | |||||||||||
Sponsor Name:Luitpold Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Single Arm, Open Label Study of the Safety, Efficacy, and Pharmacokinetics of SPRIX® (intranasal ketorolac tromethamine) in 0 to 11 year-Old Patients Undergoing Open Surgical Procedures | |||||||||||||
Medical condition: post open surgery pain (incuding but not limited to orthopedic, abdominal, thoracic, plastic/reconstructive, neurologic [spine], or urologic procedures) | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000938-35 | Sponsor Protocol Number: 1SPR11001 | Start Date*: 2013-06-22 | |||||||||||
Sponsor Name:Luitpold Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Single Arm, Open Label Study to compare the Pharmacokinetics, Safety, and Efficacy of SPRIX® (intranasal ketorolac tromethamine) in 12 to 17 Year-Old Patients vs. Adult Patients (18 - 64 Years) U... | |||||||||||||
Medical condition: post open surgery pain (incuding but not limited to orthopedic, abdominal, thoracic, plastic/reconstructive, neurologic [spine], or urologic procedures) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003278-93 | Sponsor Protocol Number: KF5503/34-R331333-PAI-3004 | Start Date*: 2007-01-31 | |||||||||||
Sponsor Name:Johnson & Johnson Pharamceutical Research & Development, L.L.C. | |||||||||||||
Full Title: Randomized, Double-Blind, Active-Control, Parallel Group, 90-Day Safety Study of CG5503 Immediate Release or Oxycodone Immediate Release in Subjects With Chronic Pain from Low Back Pain or Osteoart... | |||||||||||||
Medical condition: moderate to severe pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001133-18 | Sponsor Protocol Number: PH-2006-1 | Start Date*: 2006-05-25 | |||||||||||
Sponsor Name:Pharmos Corp. | |||||||||||||
Full Title: CANNABINOR DENTAL IMPACTION PAIN STUDY PROOF-OF-CONCEPT DOSE-RANGING STUDY | |||||||||||||
Medical condition: Cannabinor is as an analgesic and anti-inflammatory agent. By its nature, it has been designed to be more active at the CB2 peripheral receptors and have less activity at the central CB1 receptors.... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020343-13 | Sponsor Protocol Number: ESTEVE-SIGM-106 | Start Date*: 2010-06-21 | |||||||||||
Sponsor Name:Laboratorios del Dr Esteve S.A | |||||||||||||
Full Title: A double-blind, randomised, placebo-controlled, 4‑way cross-over Phase I study to investigate the pharmacokinetics, pharmacodynamics and safety of escalating single doses of E‑52862 in young health... | |||||||||||||
Medical condition: Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002239-16 | Sponsor Protocol Number: SM2-KHT-2015 | Start Date*: 2015-08-12 | ||||||||||||||||
Sponsor Name:Næstved Hospital | ||||||||||||||||||
Full Title: PANSAID – PAracetamol and NSAID in combination: A randomised, blinded, parallel 4-group clinical trial | ||||||||||||||||||
Medical condition: Pain after total hip replacement surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-001967-22 | Sponsor Protocol Number: P01799 | Start Date*: 2014-08-05 | ||||||||||||||||
Sponsor Name:Papworth Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: A phase II study to investigate the protective effects of Glucagon-like Peptide-1 (GLP-1) in patients undergoing elective angioplasty and stenting. | ||||||||||||||||||
Medical condition: To determine whether an infusion of GLP1 can reduce the occurrence of myocyte necrosis and infarction caused by percutaneous coronary intervention | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
